With new disease-modifying treatments in development, trials will require reliable classification criteria to ensure accurate comparisons between groups. To support this, EULAR – The European ...
This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).